HDIM
MR

Hanson & Doremus Investment Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Hanson & Doremus Investment Management’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-36,939
Closed -$1M – 483
2015
Q4 		$1M Sell
36,939
-1,200
-3% -$30.9K 0.45% 62
2015
Q3 		$834K Sell
38,139
-705
-2% -$18K 0.4% 72
2015
Q2 		$1.11M Buy
38,844
+2,360
+6% +$68.8K 0.47% 62
2015
Q1 		$998K Buy
36,484
+4,855
+15% +$134K 0.42% 71
2014
Q4 		$835K Buy
31,629
+475
+2% +$13.9K 0.36% 81
2014
Q3 		$940K Buy
31,154
+1,340
+4% +$41.5K 0.43% 69
2014
Q2 		$939K Hold
29,814
– – 0.43% 75
2014
Q1 		$965K Sell
29,814
-1,360
-4% -$47.6K 0.45% 72
2013
Q4 		$1.13M Hold
31,174
– – 0.54% 57
2013
Q3 		$1.21M Sell
31,174
-590
-2% -$23.8K 0.61% 52
2013
Q2 		$1.19M Buy
+31,764
New +$1.25M 0.65% 47

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Hanson & Doremus Investment Management's MR Position: Q1 2016 in Review

Hanson & Doremus Investment Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 36,939 shares — an estimated $1M sold.

Hanson & Doremus Investment Management first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $1.21M in Q3 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Hanson & Doremus Investment Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 36,939 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $1M.
  • Hanson & Doremus Investment Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Hanson & Doremus Investment Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.21M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Hanson & Doremus Investment Management's 13F filing for Q1 2016, filed 12 May 2016.